Chun Yin 'Tim' Li

Chun Yin 'Tim' Li has a diverse range of work experience, starting with their current role as a Clinical Research Associate (In-house) at Duality Biologics. In this position, they collaborate with the project manager to oversee the conduct of clinical trials and ensure compliance with ICH-GCP guidelines and federal regulations. Chun Yin 'Tim' also conducts co-monitoring visits for internal quality management and serves as quality control for the electronic Trial Master File.

Prior to their current role, Chun Yin worked as a Clinical Trial Associate at Innocube Biosciences Inc. where they gained experience in supporting clinical trials. Chun Yin 'Tim' also worked as a Clinical Trial Assistant at Klus Pharma Inc., where they assisted in various aspects of clinical trials.

Chun Yin has also gained healthcare experience through externships at the University of Maryland Medical Center, where they worked as an Acute Care General Medicine Extern, and Johns Hopkins Hospital, where they served as an Infectious Disease Pharmacy Extern and a Health System Pharmacy Extern.

Additionally, Chun Yin has completed externships at Sanofi Genzyme, where they worked in Medical Affairs, and Johns Hopkins Hospital, where they gained experience in Ambulatory Care Pharmacy and Community Pharmacy.

Chun Yin 'Tim''searly work experience includes an externship in Pharmacy Practice and Administrative at Ewha Womans University and research assistant positions at the University of Maryland, Baltimore.

Overall, Chun Yin 'Tim' Li has a strong background in clinical research, healthcare, and pharmacy practice, with experience in various settings and roles.

Chun Yin 'Tim' Li has a diverse education history. Chun Yin 'Tim' completed their Doctor of Pharmacy (PharmD) degree at the University of Maryland Baltimore in 2020. Prior to that, they obtained a degree in Molecular and Cell Biology with a specialization in Genetics from the University of California, Berkeley in 2015. In addition to their academic achievements, Li has also obtained certifications to enhance their professional qualifications. In 2021, they completed the GCP for Clinical Trials with Investigational Drugs and Medical Devices (U.S. FDA Focus) certification offered by the CITI Program, A Division of BRANY. Furthermore, in 2023, Li became an ACRP Certified Professional, obtaining certification from the Association of Clinical Research Professionals.